Intra-Cellular Therapies Inc. (ITCI) Covered Calls

Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.

You can sell covered calls on Intra-Cellular Therapies Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ITCI (prices last updated Fri 4:16 PM ET):

Intra-Cellular Therapies Inc. (ITCI) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
68.80 -1.54 69.11 72.90 878K - 6.8
Covered Calls For Intra-Cellular Therapies Inc. (ITCI)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 70 2.15 70.75 -1.1% -26.8%
Jun 21 70 4.50 68.40 2.3% 16.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Intra-Cellular Therapies, Inc. is a biopharmaceutical company, which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS. Its lead product candidate, ITI-007, is in clinical development as a first-in-class treatment for schizophrenia. The company also includes pre-clinical programs that are focused on advancing drug candidates for the treatment of cognitive dysfunction, in both schizophrenia and Alzheimer's disease, and for disease modification and the treatment of neurodegenerative disorders, including Alzheimer's disease. Intra-Cellular Therapies was founded on August 29, 2013 and is headquartered in New York, NY.